投资者关系活动记录表 编号：2022-08 证券代码：301021 证券简称：英诺激光 英诺激光科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------------|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | | 特定对象调研 □分析师会议 | | 类别 | | □媒体采访 □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | 其他 电话会议 | | | 参与单位名称及 | 海通证券 杨彤昕 | | | 人员姓名 | 招商基金 吴 | | | | 汇信资本 | 谷方庆、黄向阳 | | | 西部证券 李启文 | | | | 西南证券 周鑫雨 | | | | 安信证券 ...

Financial Performance - The company's revenue for Q3 2022 was ¥71,069,977.37, a decrease of 22.23% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of ¥3,712,260.56, representing a decline of 114.37% year-on-year[5] - The net profit after deducting non-recurring gains and losses was a loss of ¥4,961,192.01, down 124.70% from the previous year[5] - Total operating revenue for Q3 2022 was ¥241,146,295.04, a decrease of 18.0% compared to ¥294,103,293.38 in Q3 2021[26] - Operating profit for Q3 2022 was ¥25,520,940.54, a decline of 65.2% from ¥73,461,293.23 in Q3 2021[26] - The company reported a net profit margin of approximately 10.6% for Q3 2022, down from 24.9% in Q3 2021[26] - The net profit for the third quarter was approximately ¥23.44 million, compared to ¥66.74 million in the previous year, indicating a decrease of about 64.9%[27] - The total comprehensive income for the third quarter was approximately ¥33.63 million, down from ¥66.51 million in the same period last year, a decrease of about 49.5%[27] - Basic and diluted earnings per share for the third quarter were both ¥0.1511, down from ¥0.5249 in the previous year, reflecting a decline of about 71.2%[27] Cash Flow and Investments - The operating cash flow for the year-to-date reached ¥97,021,057.28, an increase of 451.45% compared to the same period last year[5] - The operating cash flow for the third quarter was approximately ¥97.02 million, significantly higher than ¥17.59 million in the same period last year, showing an increase of about 438.5%[29] - The net cash flow from investing activities was negative at ¥-83,350,338.30, a decline of 212.20% year-on-year, attributed to increased investments in financial products and construction projects[15] - The company reported a net cash outflow from investment activities of approximately ¥83.35 million, compared to a net outflow of ¥26.70 million in the previous year[30] - The company received cash inflows from investment activities totaling approximately ¥194.73 million, with cash outflows of approximately ¥278.08 million, resulting in a net cash outflow of ¥83.35 million[30] Assets and Liabilities - Total assets at the end of Q3 2022 were ¥1,074,935,383.29, a decrease of 2.46% from the end of the previous year[5] - Cash and cash equivalents as of September 30, 2022, were ¥346,389,183.13, down from ¥359,850,342.13 at the beginning of the year[23] - Total current assets decreased to ¥800,328,622.16 from ¥832,771,985.75 at the start of the year, reflecting a decline of 3.9%[23] - Total liabilities decreased to ¥82,657,555.34 from ¥126,352,506.21, indicating a reduction of 34.6%[24] - Total equity attributable to shareholders increased to ¥989,436,374.07 from ¥973,798,039.73, showing a growth of 1.6%[24] Shareholder Information - The top 10 shareholders hold significant stakes, with DeTai International Investment Group owning 28.10% (42,580,000 shares) and Shenzhen Hongcui Investment Enterprise holding 25.72% (38,970,000 shares) [18] - The company reported a total of 117,445,082 restricted shares at the beginning of the period, with 35,895,082 shares released, leaving 81,550,000 restricted shares at the end of the period [20] - The company has a diverse shareholder base, including both domestic and foreign entities, with the largest shareholder being a foreign legal entity [18] - The company has not disclosed any known relationships or concerted actions among its shareholders, except for one natural person shareholder who is a partner in another investment entity [19] - The company has a total of 10,030,000 unrestricted shares held by Shenzhen Huishang Investment Enterprise, which is the largest among the unrestricted shareholders [20] - The company has a total of 3,800,000 shares held under a collective asset management plan by Great Wall Securities and China Construction Bank [20] Research and Development - Research and development expenses for Q3 2022 were ¥41,799,096.18, an increase of 9.0% compared to ¥38,093,325.71 in Q3 2021[26] - The company has not reported any new product developments or technological advancements in this quarter [22] - The company plans to focus on market expansion and new product development in the upcoming quarters[25] Market Strategy and Outlook - There are no significant market expansion or acquisition strategies mentioned in the report [22] - The company has not provided specific future outlook or performance guidance in this report [22] Other Comprehensive Income - The company reported a significant increase of 1666.29% in other comprehensive income, totaling ¥9,581,695.98, due to the appreciation of the US dollar[10] - The other comprehensive income attributable to the parent company was approximately ¥9.79 million, compared to a loss of ¥0.21 million in the previous year, indicating a significant improvement[27]

Financial Performance - The company reported a revenue of RMB 100 million for the first half of 2022, representing a year-on-year increase of 20%[20] - The gross profit margin for the first half of 2022 was 45%, compared to 40% in the same period last year[20] - The company's operating revenue for the reporting period was ¥170,076,317.67, a decrease of 16.10% compared to the same period last year[27] - The net profit attributable to shareholders was ¥26,623,025.64, down 34.20% year-on-year[27] - The net profit after deducting non-recurring gains and losses was ¥17,094,392.67, reflecting a decline of 35.04% compared to the previous year[27] - The net cash flow from operating activities increased significantly to ¥67,011,917.99, a rise of 7,437.92% from the previous year[27] - The company achieved operating revenue of 170.08 million yuan, a year-on-year decrease of 16.10%[68] - The net profit attributable to shareholders was 26.62 million yuan, down 34.20% year-on-year[60] - The total comprehensive income for the first half of 2022 was CNY 32,191,968.75, down from CNY 41,543,519.00 in the same period of 2021[193] Market Expansion and Strategy - The company plans to invest RMB 50 million in R&D for new laser technologies in the upcoming year[20] - User data indicates a 30% increase in active users of the company's laser products compared to the previous year[20] - The company is expanding its market presence in Southeast Asia, aiming for a 15% market share by the end of 2023[20] - The company is focusing on expanding its market presence in the biomedical field, leveraging its core technologies in laser applications[64] - The company is expanding its market presence in the micro-processing and new energy sectors, with a focus on high-quality development[102] - The company is actively developing new products, including laser equipment for medical applications[107] Research and Development - The company focuses on the R&D, production, and sales of laser devices and embedded laser modules, serving various industries including consumer electronics and biomedical[35] - The company has established R&D centers in both China and the United States, enhancing its technological innovation capabilities and maintaining competitiveness in core technologies[40] - Research and development expenses increased by 6.14% year-on-year, totaling 27.16 million yuan[68] - The company applied for a total of 25 intellectual property rights during the reporting period, including 13 invention patents[63] - The establishment of a joint laboratory for photoacoustic imaging was completed, enhancing product clinical transformation capabilities[65] Financial Position and Assets - The total assets at the end of the reporting period were ¥1,089,758,646.35, a decrease of 1.12% from the end of the previous year[27] - The net assets attributable to shareholders increased to ¥989,950,902.45, marking a growth of 1.66% compared to the previous year[27] - Cash and cash equivalents decreased to CNY 249,897,038, down 9.72% from CNY 359,850,342 at the end of the previous year[75] - The company’s inventory stood at CNY 173,483,506, a slight decrease of 0.27% compared to CNY 178,465,296 at the end of the previous year[75] - The company reported a significant increase in trading financial assets, rising to ¥195,262,805.47 from ¥47,050,924.71, representing a growth of approximately 315.5%[184] Risks and Challenges - The company faces risks related to supply chain disruptions and is implementing strategies to mitigate these risks[4] - The company faces risks from macroeconomic uncertainties, including global political and economic factors, which may impact industry demand and costs[102] - To address competition risks, the company plans to optimize product design and leverage brand advantages to maintain a high gross margin[104] - The company is focused on innovation-driven development to mitigate management risks associated with scaling operations[105] Shareholder and Corporate Governance - No cash dividends or stock bonuses will be distributed to shareholders for the current fiscal year[5] - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[112] - A stock incentive plan was approved, granting a total of 3 million restricted stocks, representing 1.98% of the company's total share capital[114] - The company has not engaged in any related party transactions during the reporting period, including asset or equity acquisitions or joint investments[134][135] - The company has confirmed that there are no violations in the management of raised funds and all related information has been disclosed accurately and completely[93] Corporate Social Responsibility - The company emphasizes its commitment to social responsibility and aims to balance economic, environmental, and social factors[119] - The company has not experienced any significant environmental penalties during the reporting period[118] Investor Relations - The company conducted multiple investor communications to discuss its strategic direction and financial performance[107] - The company held its first temporary shareholders' meeting on April 8, 2022, with an investor participation rate of 14.60%[110] - The annual shareholders' meeting on May 13, 2022, had a participation rate of 60.69%[110] - The second temporary shareholders' meeting on June 1, 2022, saw a participation rate of 53.79%[110]

Revenue and Profitability - Revenue for Q1 2022 was CNY 80,498,706.84, a decrease of 6.49% compared to CNY 86,081,994.81 in the same period last year[4] - Net profit attributable to shareholders was CNY 12,394,501.00, down 36.64% from CNY 19,562,925.67 year-over-year[4] - Basic earnings per share decreased by 52.53% to CNY 0.0817 from CNY 0.1721 in the previous year[4] - Total operating revenue for Q1 2022 was CNY 80,498,706.84, a decrease of 6.1% compared to CNY 86,081,994.81 in the same period last year[25] - Net profit for Q1 2022 was CNY 13,177,021.23, a decline of 36.5% compared to CNY 20,856,576.52 in Q1 2021[27] - The company's gross profit margin for Q1 2022 was approximately 20.1%, compared to 22.5% in the previous year[25] - The company reported a comprehensive income of CNY 12,795,350.23 for Q1 2022, compared to CNY 21,445,131.21 in the same period last year[27] Cash Flow - Net cash flow from operating activities increased significantly by 715.88% to CNY 36,022,107.70, compared to a negative cash flow of CNY -5,848,870.48 in the same period last year[4] - The net cash flow from operating activities was ¥36,022,107.70, a significant improvement compared to a net outflow of ¥5,848,870.48 in the previous period[29] - Total cash inflow from operating activities amounted to ¥118,694,498.59, up from ¥81,846,384.61 in the prior period, reflecting a growth of approximately 45%[29] - Cash outflow from operating activities decreased to ¥82,672,390.89 from ¥87,695,255.09, indicating a reduction of about 5%[29] - The net cash flow from investment activities was -¥145,188,347.79, compared to -¥14,388,363.28 in the previous period, showing a substantial increase in cash outflow[30] - Cash inflow from investment activities totaled ¥40,447,731.48, while cash outflow reached ¥185,636,079.27, resulting in a negative cash flow from investments[30] - The net cash flow from financing activities was -¥496,017.55, a decrease from -¥41,985,830.24 in the previous period, indicating improved cash management[30] - The company received ¥40,000,000.00 from borrowings during the financing activities, which was a significant source of cash inflow[30] - The company reported a cash outflow of ¥85,450,000.00 for debt repayment, highlighting its commitment to managing liabilities[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,098,994,866.41, a slight decrease of 0.28% from CNY 1,102,062,134.78 at the end of the previous year[4] - The total assets as of the end of Q1 2022 were CNY 1,098,994,866.41, a slight decrease from CNY 1,102,062,134.78 at the end of the previous quarter[24] - Total liabilities decreased to CNY 110,505,409.68 in Q1 2022 from CNY 126,352,506.21 in the previous quarter[24] - The company's cash and cash equivalents at the end of the period amount to ¥245,326,266.63, down from ¥359,850,342.13 at the beginning of the year[22] - The company's cash and cash equivalents were CNY 827,757,397.79, showing a minor decrease from CNY 832,771,985.75 in the previous quarter[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,232[16] - The largest shareholder, DeTai International Investment Group Limited, holds 28.08% of shares, totaling 42,580,000 shares[16] - The second largest shareholder, Shenzhen Hongcui Investment Enterprise (Limited Partnership), holds 25.70% of shares, totaling 38,970,000 shares[16] - The company has a total of 119,217,416 shares subject to lock-up agreements, with 1,772,334 shares released during the period[20] - The company plans to release the lock-up on shares held by major shareholders on July 6, 2022[19] Expenses and Investments - The company’s sales expenses decreased by 42.22% to CNY 3,990,227.68, attributed to reduced promotional activities due to the pandemic[12] - Research and development expenses for Q1 2022 were CNY 11,790,554.10, slightly down from CNY 12,059,703.98 in the same quarter last year[25] - Investment income for the period was CNY 461,018.33, primarily from the maturity of structured deposits[12] Financial Reporting - The report for the first quarter was not audited, which may affect the reliability of the financial data presented[31] - The company has not disclosed any significant new strategies or product developments during the reporting period[21]

Financial Performance - The company's revenue for Q1 2022 was ¥80,498,706.84, a decrease of 6.49% compared to ¥86,081,994.81 in the same period last year[4] - Net profit attributable to shareholders was ¥12,394,501.00, down 36.64% from ¥19,562,925.67 year-on-year[4] - Basic and diluted earnings per share were both ¥0.1091, reflecting a decline of 36.61% compared to ¥0.1721 in the same period last year[4] - Total operating revenue for Q1 2022 was CNY 80,498,706.84, a decrease of 6.1% compared to CNY 86,081,994.81 in Q1 2021[24] - Net profit for Q1 2022 was CNY 13,177,021.23, a decline of 36.5% from CNY 20,856,576.52 in Q1 2021[26] - The company's gross profit margin for Q1 2022 was approximately 20.2%, compared to 22.5% in Q1 2021[24] - The company reported a comprehensive income total of CNY 12,795,350.23 for Q1 2022, compared to CNY 21,445,131.21 in the same period last year, indicating a significant decline[26] Cash Flow - The net cash flow from operating activities increased significantly to ¥36,022,107.70, a 715.88% improvement from -¥5,848,870.48 in the previous year[4] - Cash inflow from operating activities totaled CNY 118,694,498.59, compared to CNY 81,846,384.61 in the prior period, reflecting a growth of approximately 45%[28] - Cash outflow from operating activities decreased to CNY 82,672,390.89 from CNY 87,695,255.09, indicating a reduction of about 6%[28] - The net cash flow from investing activities was -¥145,188,347.79, a 909.07% decline compared to -¥14,388,363.28 in the previous year, mainly due to the purchase of structured deposits[14] - The net cash flow from investing activities was negative CNY 145,188,347.79, worsening from a negative CNY 14,388,363.28 in the previous period[30] - Total cash inflow from investing activities was CNY 40,447,731.48, while cash outflow reached CNY 185,636,079.27, resulting in a net outflow[30] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,098,994,866.41, a slight decrease of 0.28% from ¥1,102,062,134.78 at the end of the previous year[4] - Total liabilities decreased to CNY 110,505,409.68 in Q1 2022 from CNY 126,352,506.21 in Q1 2021, reflecting a reduction of 12.6%[23] - The company's cash and cash equivalents at the end of the period amount to ¥245,326,266.63, down from ¥359,850,342.13 at the beginning of the year[21] - The company's cash and cash equivalents were CNY 827,757,397.79, showing a marginal decrease from CNY 832,771,985.75 in the previous year[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,232[16] - The largest shareholder, DeTai International Investment Group Limited, holds 28.08% of shares, totaling 42,580,000 shares[16] - The second-largest shareholder, Shenzhen Hongcui Investment Enterprise, holds 25.70% of shares, totaling 38,970,000 shares[16] Inventory and Receivables - The company experienced a 65.40% increase in accounts payable, reaching ¥43,056,656.00, attributed to increased inventory levels[9] - Accounts receivable decreased to ¥123,159,511.79 from ¥142,649,607.32, a decline of 13.7%[21] - Inventory at the end of the period is ¥179,034,201.34, slightly up from ¥178,465,296.24[21] Research and Development - Research and development expenses for Q1 2022 were CNY 11,790,554.10, slightly down from CNY 12,059,703.98 in the same period last year[24] Other Information - The company received government subsidies amounting to ¥1,275,130.57 during the reporting period[7] - The company has not disclosed any new product developments or market expansion strategies in the current report[20] - The first quarter report was not audited, indicating that the figures presented are preliminary and subject to change[31] - The company plans to release restricted shares totaling 119,217,416, with a significant portion set to be released on July 6, 2022[19] - The company has a total of 1,772,334 shares that will be released from restrictions on January 6, 2022[19]

Financial Performance - The company's operating revenue for 2021 was ¥390,976,202.73, representing a 15.32% increase compared to ¥339,048,930.36 in 2020[19]. - The net profit attributable to shareholders for 2021 was ¥74,909,120.89, up 14.24% from ¥65,573,305.53 in 2020[19]. - The company's total revenue for 2021 was ¥390,976,202.73, representing a year-on-year increase of 15.32% compared to ¥339,048,930.36 in 2020[86]. - The net cash flow from operating activities decreased by 62.39% to ¥25,347,886.34 in 2021 from ¥67,392,115.84 in 2020[19]. - The company reported a basic earnings per share of ¥0.5647 for 2021, a decrease of 2.13% from ¥0.5770 in 2020[19]. - The company achieved a revenue of 390.98 million yuan in 2021, representing a year-on-year growth of 15.32%[66]. - The net profit attributable to shareholders was 74.91 million yuan, with a year-on-year increase of 14.24%[66]. - The company reported a total revenue of 1.5 billion RMB for the fiscal year 2021, representing a year-over-year growth of 20%[168]. Dividend Distribution - The company plans to distribute a cash dividend of 1.20 RMB per 10 shares to all shareholders, based on a total of 151,645,082 shares[4]. - The company has a total of 151,645,082 shares outstanding, which serves as the basis for its profit distribution plan[4]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, highlighting potential operational risks and corresponding mitigation strategies[4]. - The company anticipates risks from macroeconomic uncertainties and intensified industry competition, and it plans to adopt strategies to mitigate these risks[140][141]. - The company is addressing risks associated with product price declines through effective cost management and supply chain strategies[145]. Research and Development - The company applied for 55 intellectual property rights in 2021, including 15 invention patents and 20 utility model patents[71]. - The company has established R&D centers in both North America and China, enhancing its technological capabilities and market responsiveness[62]. - The company is focusing on technological innovation and collaboration between its innovation center and North American R&D center to stay ahead in the market[137][138]. - The R&D expenditure for 2021 was 200 million RMB, accounting for 13.3% of total revenue, aimed at enhancing product innovation[168]. - The company has restructured its R&D functions in North America and domestically to enhance its technological capabilities and product development[101]. Market Position and Strategy - The company is a leading domestic manufacturer of micro-processing lasers and the first listed company in this sector, possessing core technologies for nanosecond, sub-nanosecond, picosecond, and femtosecond micro-processing lasers[41]. - The company aims to enhance its market share in the laser industry and expand its presence in the US market, focusing on sectors like new energy, semiconductors, and biomedicine[135]. - The company is committed to becoming a global leader in laser solutions, with a mission to benefit humanity through laser technology[131][132]. - The company is actively exploring new application areas for its laser products, which are expected to drive future growth[147]. Subsidiaries and Operations - The company has a full subsidiary named Shenzhen Yingwei Intelligent Technology Co., Ltd.[12]. - The company has a full subsidiary named Jiangsu Weina Laser Application Technology Research Institute Co., Ltd.[12]. - The company has a full subsidiary named Advanced Optowave Corporation in the United States[12]. - The company maintains a direct sales model, with domestic sales managed by its subsidiary in Changzhou and international sales primarily through its overseas subsidiary AOC[48]. Corporate Governance - The company strictly adheres to regulations and continuously improves its corporate governance structure, ensuring compliance with relevant laws and guidelines[150]. - The company has 7 board members, including 3 independent directors, who actively participate in training and decision-making processes[152]. - The company maintains complete independence from its controlling shareholder, with no guarantees or non-operational fund occupation reported during the reporting period[151]. - The company has established an independent financial department with a complete financial accounting system, ensuring independent financial decision-making[161]. Employee and Management - The total number of employees at the end of the reporting period was 361, with 84 in the parent company and 277 in major subsidiaries[198]. - The professional composition included 164 production personnel, 32 sales personnel, 112 technical personnel, 12 financial personnel, and 41 administrative personnel[198]. - The company conducts regular training needs assessments and develops annual training plans to enhance employee skills[200]. - The company has a diverse management team with experience in various sectors, including finance and technology[185]. Financial Position - Cash and cash equivalents increased by 473.17% to ¥164,160,549.38, reflecting a significant inflow from financing activities[103]. - The company raised CNY 359,480,000.00 through its IPO, with a net amount of CNY 308,463,526.34 after deducting issuance costs[117]. - The balance of the fundraising account as of December 31, 2021, was RMB 158,470,764.73, with a discrepancy of RMB 1,059,195.25 attributed to bank interest and financial product income[119]. - The company has established a complete asset control system, independent of its controlling shareholder[158].

证券代码：301021 证券简称：英诺激光 公告编号：2021-035 英诺激光科技股份有限公司 关于参加2021深圳辖区上市公司投资者网上 集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，英诺激光科技股份有限公司（以下简称 "公司"）将参加由深圳上市公司协会、深圳市全景网络有限公司共同举办的 "沟通传递价值，交流创造良好生态"——2021 深圳辖区上市公司投资者网上集 体接待日活动，现将有关事项公告如下： 本次集体接待日活动将在深圳市全景网络有限公司提供的网上平台，采取网 络远程的方式举行，投资者可以关注微信公众号：全景财经，或登录"全景•路演 天下"网站（http://rs.p5w.net/），参与公司本次投资者集体接待日活动，活动 时间为 2021 年 11 月 30 日 14:00 至 17:00,其中公司与投资者网上互动时间为 15:30 至 17:00。 届时公司的主要高级管理人员将通过网络文字交流形式与投资者进行沟通。 欢迎广大投资者积极参与。 特此公告。 英诺激光科技股份有限公司董事会 20 ...

Financial Performance - The company's revenue for Q3 2021 reached ¥91,385,219.87, representing a 10.97% increase year-over-year, while the year-to-date revenue increased by 36.30% to ¥294,103,293.38[4] - Net profit attributable to shareholders for Q3 2021 was ¥25,838,105.67, an increase of 88.96% compared to the same period last year, with a year-to-date net profit of ¥66,296,335.71, up 125.49%[4] - The basic earnings per share for Q3 2021 was ¥0.1704, reflecting a 41.62% increase year-over-year, and the year-to-date figure was ¥0.5249, up 102.90%[5] - Total revenue for Q3 2021 reached ¥294,103,293.38, an increase of 36.3% compared to ¥215,772,675.44 in Q3 2020[25] - Operating profit for Q3 2021 was ¥73,461,293.23, significantly higher than ¥29,515,198.07 in Q3 2020, marking a year-over-year increase of 148.5%[25] - The net profit for Q3 2021 was CNY 66,737,215.79, a significant increase of 127.5% compared to CNY 29,327,371.75 in Q3 2020[26] - The basic and diluted earnings per share for Q3 2021 were both CNY 0.5249, up from CNY 0.2587 in the same period last year, representing a growth of 103.5%[26] - The company reported a total comprehensive income of CNY 66,507,216.96 for Q3 2021, compared to CNY 27,968,474.80 in Q3 2020, reflecting a growth of 137.5%[26] Assets and Liabilities - Total assets as of September 30, 2021, amounted to ¥1,103,485,150.19, a 37.75% increase from the end of the previous year, while equity attributable to shareholders increased by 63.23% to ¥966,856,318.40[5] - Total assets as of the end of Q3 2021 were CNY 801,052,827.50, reflecting a strong asset base for future growth[30] - Current assets totaled ¥842,311,363.17 as of September 30, 2021, an increase of 52.5% from ¥551,778,259.93 at the end of 2020[22] - Total liabilities decreased to ¥135,376,108.20 from ¥207,896,758.98, a reduction of 34.8%[23] - Shareholders' equity increased to ¥968,109,041.99 from ¥593,156,068.52, reflecting a growth of 63.3%[23] - Total liabilities reached ¥207,896,758.98, down by ¥6,096,180.08 from the last reporting period[33] - Current liabilities totaled ¥171,717,011.15, reflecting a decrease of ¥4,656,284.73[33] - Non-current liabilities were reported at ¥36,179,747.83, a decrease of ¥1,439,895.35[33] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥17,593,732.88, showing a decrease of 33.04% compared to the previous year[4] - Cash flow from operating activities generated a net cash inflow of CNY 17,593,732.88, down 33.1% from CNY 26,274,317.28 in Q3 2020[28] - Total cash and cash equivalents at the end of Q3 2021 reached CNY 415,128,175.28, an increase of 128.5% from CNY 181,809,378.36 at the end of Q3 2020[29] - Cash inflow from financing activities was CNY 379,723,871.85, a substantial increase from CNY 93,535,089.88 in the previous year[29] - The company incurred a net cash outflow from investing activities of CNY 26,697,505.50, compared to a net outflow of CNY 12,016,385.25 in Q3 2020[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 25,338[15] - The largest shareholder, DeTai International Investment Group Limited, holds 28.08% of shares, totaling 42,580,000 shares[15] - Shenzhen Hongcui Investment Enterprise (Limited Partnership) is the second-largest shareholder with a 25.70% stake, amounting to 38,970,000 shares[15] - The company has a total of 119,217,416 restricted shares at the end of the reporting period[19] - The company has no preferred shareholders as of the reporting date[17] - The total number of restricted shares held by DeTai International Investment Group Limited and Shenzhen Hongcui Investment Enterprise is 81,550,000 shares, which will be released on July 6, 2024[18] - The company reported a total of 1,772,334 shares under offline issuance restrictions[19] - The company has a total of 10,030,000 shares held by Shenzhen Huishang Investment Enterprise (Limited Partnership), which are also restricted[18] - The company has a total of 3,800,000 shares under the management plan of Changcheng Securities and Construction Bank, which are restricted until July 6, 2022[18] Expenses - The company experienced a 50.17% increase in sales expenses, totaling ¥24,310,606.20, attributed to the expansion of sales channels[11] - Research and development expenses for Q3 2021 were ¥38,093,325.71, compared to ¥32,141,904.82 in Q3 2020, an increase of 18.5%[25] Other Information - The company reported a significant increase in other income, which reached ¥24,044,853.87, a 265.16% increase year-over-year, primarily due to government subsidies received[12] - The report for the third quarter was not audited[35] - The company has a capital reserve of ¥233,821,112.89[34] - The undistributed profits amounted to ¥226,541,491.64[34] - The company executed a retrospective adjustment of ¥6,096,180.08 for the right-of-use assets due to the new leasing standards[34]

Financial Performance - The company's operating revenue for the first half of 2021 was ¥202,718,073.51, representing a 51.93% increase compared to ¥133,425,058.48 in the same period last year[20]. - The net profit attributable to shareholders for the first half of 2021 was ¥40,458,230.04, a significant increase of 157.26% from ¥15,726,733.31 in the previous year[20]. - The net profit after deducting non-recurring gains and losses was ¥26,316,406.14, up 124.25% from ¥11,735,298.14 in the same period last year[20]. - The basic earnings per share for the first half of 2021 was ¥0.3560, an increase of 157.23% compared to ¥0.1384 in the previous year[20]. - The company reported a negative net cash flow from operating activities of ¥913,227.11, a decline of 105.13% compared to a positive cash flow of ¥17,794,967.81 in the same period last year[20]. - The weighted average return on equity for the first half of 2021 was 6.60%, an increase of 3.68% from 2.92% in the previous year[20]. - The company's revenue for the reporting period reached ¥202,718,073.51, representing a year-on-year increase of 51.93% due to business expansion and the impact of the pandemic in the previous year[43]. - The gross profit margin for laser products was 52.06%, with a 39.58% increase in revenue compared to the previous year, while the gross profit margin for laser modules was 55.15%[45]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,133,127,666.79, reflecting a 41.45% increase from ¥801,052,827.50 at the end of the previous year[20]. - The net assets attributable to shareholders at the end of the reporting period were ¥940,829,241.23, a 58.84% increase from ¥592,326,455.18 at the end of the previous year[20]. - The total liabilities decreased to ¥176,132,441.54 from ¥219,939,823.04, reflecting a reduction of 20.0%[153]. - Cash and cash equivalents increased significantly to ¥432,441,335.52 from ¥142,417,956.31, marking a growth of 203.0%[151]. - The company's inventory rose to CNY 186,353,775.99, compared to CNY 145,698,946.14 at the end of 2020, marking an increase of approximately 27.8%[146]. - The accounts receivable increased to CNY 175,728,996.08 from CNY 165,369,811.07, which is an increase of about 6.8%[146]. Research and Development - Research and development expenses increased by 23.38% to ¥25,591,581.84, driven by an increase in R&D personnel and new product development[43]. - The company has increased its R&D investment to enhance core technology and product innovation, resulting in multiple invention patents[78]. - The company launched several new laser products, including a 25W UV solid laser with intelligent point-switching capabilities and a high-energy pulsed infrared picosecond laser for cutting transparent materials[30]. - The company plans to focus on the biomedical field as a key development direction, expanding its capabilities in precision drilling and laser micro-welding for medical devices[31]. Market and Competition - The company faces risks related to market competition, with competitors including major firms like Coherent and Trumpf[80]. - The company operates R&D, production, and sales systems in both China and the United States, enhancing its market responsiveness[36]. - The laser processing technology is expected to replace traditional machining methods, providing significant market opportunities for the company[33]. - The company has a diverse customer base across over 20 countries, including the USA, Germany, and Japan, focusing on industries such as consumer electronics and biomedical[41]. Corporate Governance and Shareholder Matters - The company plans not to distribute cash dividends or issue bonus shares for the reporting period[5]. - The company has not encountered any issues regarding the use and disclosure of raised funds as of June 30, 2021[67]. - The company issued 38 million new shares, increasing the total share count from 113.65 million to 151.65 million[124]. - The proportion of shares held by domestic legal entities decreased from 62.53% to 50.53% after the issuance of new shares[124]. - The company was approved for its initial public offering (IPO) on July 6, 2021, and listed on the Shenzhen Stock Exchange[125]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[174]. - The management has provided a positive outlook for the second half of 2021, expecting continued revenue growth and profitability improvements[182]. - The company’s future outlook includes potential market expansion and new product development strategies[1].